Key Functions Of Medical Affairs In Companies
Medical affairs are no longer just a support function—they’re becoming the heartbeat of pharma and biotech. From guiding drug research to shaping clinical trials and influencing physician decisions, they put patient-centric science first. Discover how this shift is redefining the industry.
Medical affairs have diverse functions, which has been changing in the past and still is evolving.
The changes in medical affairs develop at a different pace in the big pharma compared to a biotech environment. Biotech companies have a flexible structure; their size and culture both serve to adapt faster to the changing environment than big pharma companies.
Typically, the medical affairs department's functions are:
- Provision of information and education
- Management of publications
- Clinical trials input, developing field-based relationships
- Providing both clinical and commercial support
Apart from the above functions, the key responsibilities of medical affairs also depend on the size and location of the company. The activity across the industry varies significantly between companies. These activities are mainly around the key function of the physician assigned to a therapeutic area, a specific indication, or a brand.
The functions that most companies include are:
- Publications
- Medical communication/medical information
- Health economics
- Outcomes research (HEOR)
In some companies, these groups are functionally led by the physician of the medical affairs department.
Medical affairs are increasingly playing a central role in coordinating internal company stakeholders (including commercial, market access, regulatory, clinical development, and drug safety teams) with the needs of external stakeholders. Medical…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!